Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach-Reference-Cited by-同舟云学术

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

Published:2018-01-26 Issue:1 Volume:13 Page:e0191722
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Xiaoyan^ORCID,Keshishian Allison,Hamilton Melissa,Horblyuk Ruslan,Gupta Kiran,Luo Xuemei,Mardekian Jack,Friend Keith,Nadkarni Anagha,Pan Xianying,Lip Gregory Y. H.,Deitelzweig Steve

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Discovery of anticoagulant drugs: a historical perspective;A Gómez-Outes;Curr Drug Discov Technol,2012

2. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events;YH Mekaj;Ther Clin Risk Manag,2015

3. Dabigatran versus warfarin in patients with atrial fibrillation;SJ Connolly;N Engl J Med,2009

4. Edoxaban versus warfarin in patients with atrial fibrillation;RP Giugliano;N Engl J Med,2013

5. Apixaban versus warfarin in patients with atrial fibrillation;CB Granger;N Engl J Med,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perils of reduced dose apixaban in atrial fibrillation/flutter – A case report with a brief literature review;The American Journal of the Medical Sciences;2024-08

2. Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage;Journal of Thrombosis and Haemostasis;2023-10

3. Analysis of the WATCHMAN on the Reduction of Stroke Compared to Anticoagulants: A Systematic Review of the Literature;Open Journal of Internal Medicine;2023

4. Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study;Thrombosis Journal;2022-05-02

5. Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia;Journal of Personalized Medicine;2022-03-23